Treatment of rheumatoid arthritis with a tumor necrosis factor receptor- Fc fusion protein [5] (multiple letters)

New England Journal of Medicine

Volumn 337, Issue 21, 1997, Pages 1559-1561

  Epstein, W V ^a   Mannik, M ^a   Wener, M ^a   Moreland, L W ^a   Widmer, M B ^a   Blosch, C M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIGENICITY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INJECTION SITE; LETTER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ARTHRITIS, RHEUMATOID; DOUBLE-BLIND METHOD; HUMANS; IMMUNOGLOBULIN G; PLACEBO EFFECT; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS;

EID: 0030686491     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199711203372118     Document Type: Letter

References (0)